Skip to main content

South Worcestershire, Redditch & Bromsgrove, Wyre Forest

After prompting, I received this reply:

Dear Mr Cahm

Sorry for the the delay in responding to the letters that you sent to the three Worcestershire CCGs about Freestyle Libre on 22nd March.

As you are aware National guidance published by NHS England on 7th March 2019 outlined the requirements and clinical criteria for use of Flash Glucose Monitoring (FlashGM, specifically Freestyle Libre®); this guidance has informed arrangements agreed by Worcestershire Clinical Commissioning Groups (Redditch and Bromsgrove, South Worcestershire and Wyre Forest) for the 2019/20 financial year.

The Worcestershire CCG arrangements make provision for consideration of appropriate patients at annual diabetes review. Patients who meet the referral criteria will be referred to diabetes specialist teams in hospital. This means that patients will not be able to access FlashGM sensors immediately from their general practice on 1st April 2019.

Following referral from general practice, diabetes specialist services will assess eligibility for FlashGM in accordance with national clinical criteria.  Diabetes specialist services will also be responsible for providing training, initiating use, supplying sensors and assessing eligibility for continuation. General practice will not issue any prescriptions for sensors during this initial 4 to 6 month period.

Patients who have previously self-funded use of FlashGM will be managed as outlined above.

The policies for use of FlashGM in adults and children and young people are available on the CCGs website using the following links:

http://www.southworcsccg.nhs.uk/EasySiteWeb/GatewayLink.aspx?alId=175987


We hope this clarifies the arrangements for access to Flash Glucose Monitoring  in Worcestershire.
Best wishes
Medicines Commissioning Team
NHS South Worcestershire Clinical Commissioning Group
NHS Redditch & Bromsgrove CCG and NHS Wyre Forest CCG

Update

I subsequently asked them whether they understood that this statement indicated that the sensors would be dispensed from hospitals and hence wouldn't be reimbursed.  They stated this:

We are aware of the fact that reimbursement will only be for issues via FP10 and this is how Freestyle Libre will be supplied to Worcestershire patients.

Comments

Popular posts from this blog

The CCG Project!

In order to find out the situation around the country for Libre prescribing now that the national policy has been published, I have made the decision to contact many of them to find out their plans.  I have arbitrarily chosen to contact all English CCGs that in December 2018 prescribed Libre via Primary Care to less than 5% of their population (and one specific request from a group member).  I had hoped this would be a small list, but there are 135 CCGs on the list.  I may have bitten off more than I can chew, but I'm committed to doing this and feeding back.  It worked before and hopefully this level of scrutiny will bring similar results. Below is a screenshot of the base document I am sending to each of the CCGs - it has some fields that are merge fields, so don't worry about the brackets and codes in the document (I found a typo, which has now been corrected too) .  The major piece of work with respect to this is finding the right person to contact.  However, I have s

Abbott dX 2022 Barcelona - "Make it Count"

For the past four years I've been invited by Abbott to a conference bringing together people with diabetes from across Europe to discuss various topics.  The first year I was meant to attend, it was my 'man v horse' year (the horse won!), so was unable to attend and then the pandemic hit so two further dX's were held virtually.  I was fortunate to be asked to present at last year's session.  This year's event was back in-person and held in Barcelona, coinciding with the latter part of the ATTD conference.   At this point, I must make it very clear - Abbott invited me to the 2022 European Diabetes Exchange forum (dX), that took place in Barcelona.  I attended this two-day event to connect and interact with inspirational and influential people in the diabetes community.  Abbott paid for my ticket and accommodation. #InvitedbyAbbott.  This is formal and it needs to be - I have not been required to do anything by Abbott as a result of my attendance and I hope that m

July Update - CCGs Under Pressure!

The heat is unbearable in some parts, not only in the environment, but also hopefully the heat directed at the decision-makers in 'non-compliant' CCGs who are either refusing to accept that Libre is a revolutionary tool for many T1s or have agreed to fund, but then set crippling criteria. Latest Prescribing Data Progress in prescribing continues, with stabilisation in Scotland and a continuation of the steady rise in the other three countries of the UK.  The Wales May data should be out this week. As mentioned last month, the situation in Scotland is particularly promising and the excellent Edinburgh Centre for Endocrinology and the Scottish Health Technologies Group have published documents that should significantly help the Libre case.  These documents are based on the first six months of prescribing Libre. Healthcare Improvement Scotland Statement Flash Glucose Monitoring is associated with improved glycaemic control and quality of life in people with type 1 d